Globe Life Inc. (NYSE:GL) CEO Gary L. Coleman Sells 25,000 Shares

Share on StockTwits

Globe Life Inc. (NYSE:GL) CEO Gary L. Coleman sold 25,000 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $98.93, for a total value of $2,473,250.00.

NYSE GL traded down $0.01 during midday trading on Friday, hitting $98.93. 393,200 shares of the company traded hands, compared to its average volume of 463,007. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.20. The stock has a market capitalization of $10.71 billion, a P/E ratio of 16.14, a PEG ratio of 1.80 and a beta of 0.95. The firm has a 50-day simple moving average of $95.56. Globe Life Inc. has a 52 week low of $69.68 and a 52 week high of $99.62.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, October 23rd. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.04. The business had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.13 billion. Globe Life had a return on equity of 12.21% and a net margin of 16.57%. The business’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.59 EPS. As a group, research analysts anticipate that Globe Life Inc. will post 6.77 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Friday, October 4th were given a dividend of $0.172 per share. The ex-dividend date was Thursday, October 3rd. This represents a $0.69 annualized dividend and a yield of 0.70%. Globe Life’s dividend payout ratio (DPR) is presently 11.26%.

Several research analysts have commented on the company. UBS Group reduced their price objective on Globe Life from $85.00 to $84.00 and set a “sell” rating on the stock in a report on Thursday, October 10th. Zacks Investment Research upgraded Globe Life from a “hold” rating to a “buy” rating and set a $99.00 price objective on the stock in a report on Tuesday, September 3rd. Credit Suisse Group started coverage on Globe Life in a report on Friday, September 20th. They set an “outperform” rating and a $114.00 price objective on the stock. Finally, ValuEngine raised Globe Life from a “sell” rating to a “hold” rating in a research report on Friday, November 1st.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. California Public Employees Retirement System bought a new stake in Globe Life during the 3rd quarter valued at $88,278,000. SPF Beheer BV bought a new stake in Globe Life during the 3rd quarter valued at $85,160,000. PGGM Investments bought a new stake in Globe Life during the 3rd quarter valued at $50,205,000. Sumitomo Mitsui Trust Holdings Inc. bought a new stake in Globe Life during the 3rd quarter valued at $40,947,000. Finally, Anchor Capital Advisors LLC bought a new stake in Globe Life during the 3rd quarter valued at $28,014,000. 74.05% of the stock is currently owned by institutional investors and hedge funds.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Read More: How Do You Calculate Return on Equity (ROE)?

Insider Buying and Selling by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Columbia Banking System  Rating Increased to Strong-Buy at BidaskClub
Columbia Banking System Rating Increased to Strong-Buy at BidaskClub
Atara Biotherapeutics  Posts Quarterly  Earnings Results
Atara Biotherapeutics Posts Quarterly Earnings Results
Globe Life Inc.  CEO Gary L. Coleman Sells 25,000 Shares
Globe Life Inc. CEO Gary L. Coleman Sells 25,000 Shares
Randall D. Miles Sells 34,893 Shares of eXp World Holdings Inc  Stock
Randall D. Miles Sells 34,893 Shares of eXp World Holdings Inc Stock
Adrian Senderowicz Sells 27,232 Shares of Constellation Pharmaceuticals Inc  Stock
Adrian Senderowicz Sells 27,232 Shares of Constellation Pharmaceuticals Inc Stock
LKQ Co.  SVP Sells $199,600.00 in Stock
LKQ Co. SVP Sells $199,600.00 in Stock


 
© 2006-2019 Zolmax.